Market Cap 547.90M
Revenue (ttm) 482.04M
Net Income (ttm) 860,000.00
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.18%
Debt to Equity Ratio 0.00
Volume 1,044,990
Avg Vol 2,086,664
Day's Range N/A - N/A
Shares Out 126.83M
Stochastic %K 4%
Beta 1.66
Analysts Strong Sell
Price Target $6.00

Latest News on ORGO

Organogenesis Commends Final LCDs

Nov 15, 2024, 9:25 AM EST - 4 months ago

Organogenesis Commends Final LCDs


Organogenesis Shares ReNu® Program Update

Aug 8, 2024, 4:04 PM EDT - 8 months ago

Organogenesis Shares ReNu® Program Update